Opening - by Presidents of EHNS, ESMO and ESTRO
Wojciech Golusinski, EHNS & Solange Peters, ESMO & Ben Slotman, ESTRO
Chair: Wojciech Golusinski, Poland
Surgical Innovation: Essential for Optimal Multidisciplinary Care of Oropharyngeal Cancer
Chris Holsinger, USA
Best Presentation from Young Scientist’s Forum
Chairs: Pawel Golusinksi & Amanda Psyrri
SESSION 1: FUTURE OF SURGICAL TREATMENTS.
Chair: Jan Klozar, Czech Republic & Moderator: René Leemans, The Netherlands
Is there a role of TORS in management of p16+ unknown primary cancer of the H&N?
Vinidh Paleri, United Kingdom
3D robotic like surgery
Giovanni Succo, Italy
Novel techniques for endoscopic skull base surgery
Antoine Moya-Plana, France
Image guided surgery
Max Witjes, The Netherlands
SESSION 2: DEVELOPMENTS IN GENETICS AND DIAGNOSIS
Chair: Ruud Brakenhoff, The Netherlands & Moderator: Pierre Saintigny, France
Intratumor genetic heterogeneity: current status and clinical relevance.
Patrick Pauwels, Belgium
Liquid biopsy analysis in H&N cancer
Ingeborg Tinhofer-Keilholz, Germany
Proferred papers related to sessions 1-2
Chair: Robert Takes, The Netherlands & Moderator: Ahmet O. IKIZ, Turkey
1.1 Molecular patterns in salivary duct carcinoma identify prognostic subgroups
Simon A Mueller, Switzerland
1.2 Ex vivo functional assay for predicting radiation treatment response in squamous cell carcinoma of the head and neck.
M.E. Capala, The Netherlands
1.3 Three-dimensional margin assessment in head and neck malignancies
Jens Debacker, Belgium
1.4 EGFR-targeted fluorescence guided surgery in head and neck squamous cell carcinoma
J.G. de Wit, the Netherland
Lunch break & visit virtual sponsor booth
SESSION III: RECURRENT HEAD AND NECK CANCER-Salvage treatments in recurrent head and neck cancer
Chair: Vinidh Paleri, United Kingdom & Moderator: Jean-François Daisne, Belgium
Salvage surgery for locally recurrent head and neck cancer
Miguel Quer, Spain
Locoregional reirradiation for recurrent head and neck cancer in the IMRT and SBRT era.
Vincent Gregoire, France
Systemic therapy as monotherapy and in combination in head and neck cancer
Jan Vermorken, Belgium
PANEL: Salvage treatments in recurrent head and neck cancer: interactive case discussions
Moderators: Valentino Valentini, Italy & Antoine Digonnet, Belgium & Giovanni Succo, Italy - Case discussion
Radiotherapy: Kenneth Jensen, Denmark & Oncology: Sjoukje Oosting, The Netherlands & Oncology: Amanda Psyrri, Greece, Surgery: Gilles Dolivet, France; Surgery: Gregorio Sanchez Aniceto, Spain
Proferred papers session 3
Chair: Antti Mäkitie, Finland & Moderator: Ben-Zion Joshua, Israel
3.1 A circulating biomarker for the early detection of recurrent oral cancer.:
Cathie Garnis, Canada
3.2 Salvage Treatment in Isolated Regional Recurrent Head and Neck Squamous Cell Carcinoma
Roland Giger, Switzerland
3.3 Nasopharyngeal brush Epstein barr viral DNA in the detection of locally recurrent nasopharyngeal cancer
Jason Chan, Hong Kong
Ben-Zion Joshua, Israel
New data from randomised trials
Chair: Ana Varges Gomes, Portugal & Moderator: Andreas Dietz, Germany
Introduction by the chair
A DAHANCA-EORTC blind randomised multicentric study of concomitant chemo-radiotherapy with or without the hypoxic cell sensitiser Nimorazole for locally advanced p16-negative head and neck SCC.
Vincent Grégoire, France
Results of DARS: a randomised phase III trial of dysphagia-optimised intensity modulated radiotherapy (DO-IMRT) versus standard IMRT (S-IMRT) in oropharyngeal (OPC) and hypopharyngeal (HPC) cancer.
Chris Nutting, United Kingdom
Efficacy of Hyperbaric Oxygen in the Treatment of Osteoradionecrosis of the Mandible. Results from the combined clinical trials DAHANCA-21 and NWHHT2009-1.
François Dieleman, The Netherlands
SESSION 4: SALIVARY GLAND TUMORS
Chair: Marc Hamoir, Belgium & Moderator: Gerhard Hüber, Switzerland - Case discussion
Keynote lecture: Histology-driven surgery in parotid carcinoma: fact or fiction?
Vincent Vanderpoorten, Belgium
Surgery: Sefik Hosal, Turkey & Radiotherapy: Jean Bourhis, Switzerland & Oncology: Laura Locati, Italy & Pathology: Andrzej Marszałek, Poland
End of the congress day